Neumora Therapeutics Inc (NAS:NMRA)
$ 1.255 -0.060 (-4.58%) Market Cap: 235.81 Mil Enterprise Value: 171.29 Mil PE Ratio: 0 PB Ratio: 5.21 GF Score: 11/100

Neumora Therapeutics Inc at RBC Capital Markets Global Healthcare Conference Transcript

May 19, 2026 / 05:35 PM GMT
Release Date Price: $1.67 (-5.65%)


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

NMRA.OQ - Neumora Therapeutics Inc
Neumora Therapeutics Inc at RBC Capital Markets Global Healthcare Conference
May 19, 2026 / 05:35PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Back, everybody, and good afternoon.

I'm Brian Abrams, Senior Biotech Analyst at RBC Capital Markets. We're really pleased to have our next presenting company, Nomura Therapeutics, represented by Josh Pinto, their President, Nick Brandon, their Chief Scientific Officer, and Jason Duncan, their Chief Administrative Officer. Thanks so much, guys, for being here.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Yeah, thanks, Brian, for inviting us. Really appreciate it.

------------------------------------------------------------
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot